Economic Atlas
Companies/Pulse Biosciences, Inc.
Company profile

Pulse Biosciences, Inc.

NASDAQ: PLSE · Healthcare · Medical - Instruments & Supplies
PublicHQ Miami, CACIK 0001625101Reports USD
#958 of 1,418 Healthcare companies by revenue
EA Score
43D
Revenue TTM
$751.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$72.8M
Employees
116
as of 2026-08-09
Market cap
$2.9B
as of 2026-08-09

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$350.0k$350.0k2025
Net income-$72.8M-$72.8M2025
Operating income-$76.9M-$76.9M2025
Total assets$94.5M$94.5M2025
Liabilities$13.9M$13.9M2025
Equity$80.7M$80.7M2025

Revenue trend

FY2022 – FY2025 · USD
FY22
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2022
By product
Cycle Units Products100%
By geography
North America74%
Rest of World26%
The read

What is Pulse Biosciences, Inc.’s revenue?

Pulse Biosciences, Inc. booked $350.0k in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -20794.6% net margin.

Peers · Healthcare
Health Sciences Group, Inc.——Ultimate Sports, Inc.——Core One Labs Inc.——MedX Health Corp29DProvectus Biopharmaceuticals, Inc.35DGold River Productions, Inc.——
Key facts
CEOPaul Arthur LaViolette
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersMiami, CA
ExchangeNASDAQ: PLSE
Employees116
IPO date2016-05-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.